Νοέ22015Βιβλιογραφικά δεδομέναΓια να δείτε το άρθρο πιέστε εδώ Κατηγορία Βιβλιογραφικά δεδομένα2 Νοεμβρίου 2015 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:International Liver Congress 2016ΕπόμενοNext post:Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.Σχετικά ΆρθραA new clinical and prognostic characterization of the patterns of decompensation of cirrhosis10 Απριλίου 2024Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure1 Απριλίου 2024A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis1 Απριλίου 2024Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol- related liver disease19 Μαρτίου 2024Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC12 Μαρτίου 2024Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial5 Μαρτίου 2024
A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis10 Απριλίου 2024
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure1 Απριλίου 2024
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol- related liver disease19 Μαρτίου 2024
Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC12 Μαρτίου 2024
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial5 Μαρτίου 2024